The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab Treatment
Latest Information Update: 10 Feb 2023
At a glance
- Drugs Dupilumab (Primary)
- Indications Atopic dermatitis; Eczema
- Focus Therapeutic Use
Most Recent Events
- 06 Feb 2023 Status changed from recruiting to completed.
- 28 Feb 2022 Planned End Date changed from 11 May 2021 to 1 Jan 2023.
- 28 Feb 2022 Planned primary completion date changed from 11 May 2021 to 1 Jan 2023.